Kallidin
This article relies largely or entirely on a single source. (February 2017) |
Names | |
---|---|
IUPAC name
L-Lysyl-L-arginyl-L-prolyl-L-prolyl-glycyl-L-phenylalanyl-L-seryl-L-prolyl-L-phenylalanyl-L-arginine
| |
Identifiers | |
3D model (
JSmol ) |
|
ChemSpider | |
ECHA InfoCard
|
100.005.853 |
IUPHAR/BPS |
|
MeSH | Kallidin |
PubChem CID
|
|
UNII | |
CompTox Dashboard (EPA)
|
|
| |
| |
Properties | |
C56H85N17O12 | |
Molar mass | 1188.403 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
Kallidin is a bioactive kinin formed in response to injury from kininogen precursors through the action of kallikreins.[1]
Kallidin is a decapeptide whose sequence is H-Lys-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-OH. It can be converted to bradykinin by the aminopeptidase enzyme.
It can be a substrate for carboxypeptidase M and N.[2]
Kallidin is identical to
N-terminal end and signals through the bradykinin receptor
.
References
- ISBN 978-0-12-385095-9– via ScienceDirect.
- ISBN 978-3-540-38916-3. Retrieved 11 December 2010.